Dr. Reddy's Laboratories carries the same structural divide into its June 9 print that has defined this entire preview cycle — short sellers sitting near their highs, options traders showing no concern whatsoever.
The short position has barely moved since the last print. Shares short edged down fractionally to 19.7 million on June 4, off less than 0.25% on the day and roughly 1% on the week. The one-month build remains a steep 42%. Cost to borrow has pulled back from the 1.07% spike seen ahead of the June 5 release, settling to 0.93% — still 22% above last week's level and 55% above where it was a month ago. Availability has loosened slightly to 62.8%, up from the sub-60% readings of late May and well above the 31–33% cycle lows that briefly gripped the lending pool in the week of May 18–22. The ORTEX short score held at 57.1, essentially unmoved from its series high of 57.3 and still running materially above the mid-50s levels that defined early May. The overall message from the lending market is unchanged: a substantial short position built over the past month, a borrow rate well above its prior range, and a pool that has loosened from its tightest point but has not returned to normal.
Options traders remain on a different planet. The put/call ratio edged to 0.16 — barely changed from the 0.15 range that has anchored flow for three straight weeks. That reading is less than half the 20-day average of 0.38, and sits just off the 52-week low of 0.009. There is no hedge demand here. The z-score of -0.57 confirms options positioning is softer than usual into the print, not more defensive. The divergence between a meaningfully elevated short book and near-record call dominance in options flow is the defining feature of this setup — and it has not resolved across five consecutive earnings previews.
The one analyst action worth noting is HSBC's upgrade to Buy from Hold exactly one year ago, with a target of $16.90 against the current price of $13.24. All other recent analyst data carries currency and timeline inconsistencies — Barclays targets in the $60–$87 range reflect the Indian-listed share, not the US ADR — and cannot be reconciled with the current price level. Institutional ownership is broadly stable, with BlackRock adding just over 1.3 million shares through April 30.
The June 9 print is the latest test of whether the bear thesis — built steadily over six weeks — carries fundamental backing, or whether the options market's persistent calm turns out to be the smarter read.
See the live data behind this article on ORTEX.
Open RDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
